Literature DB >> 9690412

Anaemia in dialysis patients as a side-effect of sartanes.

A Schwarzbeck, K W Wittenmeier, U Hällfritzsch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690412     DOI: 10.1016/s0140-6736(05)60259-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Authors:  D A Sica; T W Gehr; A Fernandez
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Hypertension after renal transplantation.

Authors:  V Schwenger; M Zeier; E Ritz
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

Review 3.  Comparative safety and tolerability of angiotensin II receptor antagonists.

Authors:  L Mazzolai; M Burnier
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

Review 4.  Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.

Authors:  W J Elliott
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

5.  Anaemia correction in predialysis elderly patients: influence of the antihypertensive therapy on darbepoietin dose.

Authors:  Pedro Leão Neves; Alexandre Baptista; Elsa Morgado; Alfonso Iglesias; Hermínio Carrasqueira; Marília Faísca; Carla Soares; Ana P Silva
Journal:  Int Urol Nephrol       Date:  2006-09-26       Impact factor: 2.370

6.  Relationship between anti-erythropoietin receptor autoantibodies and responsiveness to erythropoiesis-stimulating agents in patients on hemodialysis: a multi-center cross-sectional study.

Authors:  Akinori Hara; Yoshitaka Koshino; Yukie Kurokawa; Yasuyuki Shinozaki; Taito Miyake; Shinji Kitajima; Tadashi Toyama; Yasunori Iwata; Norihiko Sakai; Miho Shimizu; Kengo Furuichi; Hiroyuki Nakamura; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2019-09-09       Impact factor: 2.801

Review 7.  Antihypertensive medications and anemia.

Authors:  Domenic A Sica; Rosemarie Mannino
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-09       Impact factor: 3.738

8.  The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.

Authors:  Jung Nam An; Jin Ho Hwang; Jung Pyo Lee; Ho Jun Chin; Sejoong Kim; Dong Ki Kim; Suhnggwon Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.